E. L. Stephen

1.1k total citations
22 papers, 804 citations indexed

About

E. L. Stephen is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, E. L. Stephen has authored 22 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Infectious Diseases and 5 papers in Immunology. Recurrent topics in E. L. Stephen's work include Influenza Virus Research Studies (5 papers), Respiratory viral infections research (5 papers) and Viral Infections and Vectors (5 papers). E. L. Stephen is often cited by papers focused on Influenza Virus Research Studies (5 papers), Respiratory viral infections research (5 papers) and Viral Infections and Vectors (5 papers). E. L. Stephen collaborates with scholars based in United States, Malaysia and Germany. E. L. Stephen's co-authors include T. W. Slone, Peter B. Jahrling, Karl M. Johnson, R. Hesse, P. B. Jahrling, Gerald A. Eddy, J. S. Walker, CJ Peters, R. O. Spertzel and C. J. Peters and has published in prestigious journals such as Science, Annals of the New York Academy of Sciences and The Journal of Infectious Diseases.

In The Last Decade

E. L. Stephen

22 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. L. Stephen United States 15 561 283 124 98 94 22 804
Ayan K. Chakrabarti United States 20 739 1.3× 190 0.7× 150 1.2× 165 1.7× 64 0.7× 29 951
Eva Mittler United States 16 750 1.3× 332 1.2× 102 0.8× 99 1.0× 30 0.3× 25 976
Shuzo Urata Japan 16 678 1.2× 335 1.2× 194 1.6× 166 1.7× 66 0.7× 46 1.1k
Laurent Guillemot France 15 276 0.5× 69 0.2× 63 0.5× 86 0.9× 79 0.8× 21 628
Mahmoud Djavani United States 22 707 1.3× 374 1.3× 86 0.7× 214 2.2× 19 0.2× 35 1.1k
John J. Suschak United States 15 371 0.7× 202 0.7× 107 0.9× 287 2.9× 89 0.9× 30 819
Malin Karlsson Sweden 12 350 0.6× 249 0.9× 62 0.5× 244 2.5× 64 0.7× 20 894
Caroline Carbonnelle France 12 783 1.4× 315 1.1× 62 0.5× 132 1.3× 18 0.2× 17 1.1k
Ewa Björling Sweden 15 449 0.8× 230 0.8× 50 0.4× 457 4.7× 22 0.2× 28 1.1k
Emily A. Bruce United States 17 427 0.8× 436 1.5× 92 0.7× 218 2.2× 18 0.2× 28 1.1k

Countries citing papers authored by E. L. Stephen

Since Specialization
Citations

This map shows the geographic impact of E. L. Stephen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. L. Stephen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. L. Stephen more than expected).

Fields of papers citing papers by E. L. Stephen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. L. Stephen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. L. Stephen. The network helps show where E. L. Stephen may publish in the future.

Co-authorship network of co-authors of E. L. Stephen

This figure shows the co-authorship network connecting the top 25 collaborators of E. L. Stephen. A scholar is included among the top collaborators of E. L. Stephen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. L. Stephen. E. L. Stephen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stephen, E. L., et al.. (2020). Evaluation of Software Requirement Specification Based on IEEE 830 Quality Properties. International Journal on Advanced Science Engineering and Information Technology. 10(4). 1396–1402. 1 indexed citations
2.
Stephen, E. L., et al.. (2017). Framework for Measuring the Quality of Software Specification. Journal of Telecommunication Electronic and Computer Engineering (JTEC). 9. 79–84. 2 indexed citations
3.
Peters, C. J., et al.. (1988). Experimental Rift Valley fever in rhesus macaques. Archives of Virology. 99(1-2). 31–44. 75 indexed citations
4.
Peters, C. J., et al.. (1986). Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator. Antiviral Research. 6(5). 285–297. 106 indexed citations
5.
Jahrling, P. B., CJ Peters, & E. L. Stephen. (1984). Enhanced Treatment of Lassa Fever by Immune Plasma Combined with Ribavirin in Cynomolgus Monkeys. The Journal of Infectious Diseases. 149(3). 420–427. 81 indexed citations
6.
Canonico, P G, et al.. (1984). Hematological and bone marrow effects of ribavirin in rhesus monkeys. Toxicology and Applied Pharmacology. 74(2). 163–172. 42 indexed citations
7.
Oishi, John, et al.. (1981). Plasma disappearance, urine excretion, and tissue distribution of ribavirin in rats and rhesus monkeys. Antimicrobial Agents and Chemotherapy. 19(6). 1042–1049. 45 indexed citations
8.
Levy, Hilton B., et al.. (1980). IMMUNE MODULATING EFFECTS OF POLY ICLC. Annals of the New York Academy of Sciences. 350(1). 33–41. 16 indexed citations
9.
Jahrling, Peter B., et al.. (1980). Lassa Virus Infection of Rhesus Monkeys: Pathogenesis and Treatment with Ribavirin. The Journal of Infectious Diseases. 141(5). 580–589. 175 indexed citations
10.
Canonico, P G, et al.. (1980). Molecular Aspects of the Antiviral Activity of Ribavirin on Venezuelan Equine Encephalomyelitis Virus. 1370–1372. 6 indexed citations
11.
12.
Scott, G. H., E. L. Stephen, & Richard F. Berendt. (1978). Activity of Amantadine, Rimantadine, and Ribavirin Against Swine Influenza in Mice and Squirrel Monkeys. Antimicrobial Agents and Chemotherapy. 13(2). 284–288. 12 indexed citations
13.
Stephen, E. L., et al.. (1977). Effect of a Nuclease-Resistant Derivative of PolyriboinosinicPolyribocytidylic Acid Complex on Yellow Fever in Rhesus Monkeys (Macaca mulatta). The Journal of Infectious Diseases. 136(1). 122–126. 55 indexed citations
14.
Stephen, E. L., et al.. (1977). Interferon Induction in Cynomolgus and Rhesus Monkeys After Repeated Doses of a Modified Polyriboinosinic-Polyribocytidylic Acid Complex. Antimicrobial Agents and Chemotherapy. 11(1). 80–83. 20 indexed citations
15.
Stephen, E. L., et al.. (1977). Swine Influenza Virus Vaccine: Potentiation of Antibody Responses in Rhesus Monkeys. Science. 197(4310). 1289–1290. 23 indexed citations
16.
Berendt, Richard F., J. S. Walker, Joseph W. Dominik, & E. L. Stephen. (1977). Response of Influenza Virus-Infected Mice to Selected Doses of Ribavirin Administered Intraperitoneally or by Aerosol. Antimicrobial Agents and Chemotherapy. 11(6). 1069–1070. 15 indexed citations
17.
Walker, J. S., E. L. Stephen, & R. O. Spertzel. (1976). Small-Particle Aerosols of Antiviral Compounds in Treatment of Type A Influenza Pneumonia in Mice. The Journal of Infectious Diseases. 133(Supplement 2). A140–A144. 36 indexed citations
18.
Crabbs, C. L., et al.. (1976). Modified polyriboinosinic-polyribocytidylic acid, an immunological adjuvant. Infection and Immunity. 14(1). 318–319. 25 indexed citations
19.
Larson, E W, E. L. Stephen, & J. S. Walker. (1976). Therapeutic Effects of Small-Particle Aerosols of Ribavirin on Parainfluenza (Sendai) Virus Infections of Mice. Antimicrobial Agents and Chemotherapy. 10(4). 770–772. 13 indexed citations
20.
Walker, J. S., et al.. (1970). The Clinical Aspects of Rift Valley Fever Virus in Household Pets: II. Susceptibility of the Cat. The Journal of Infectious Diseases. 121(1). 19–24. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026